Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for attention deficit hyperactivity disorder in children and grown-ups . In Canada, its access is managed by Health Canada. This https://tevalisdexamfetamineonli696371.canariblogs.com/vyvanse-in-canada-a-complete-guide-58139636